← All trials
NCT04614545
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2021
- Primary completion
- Aug 27, 2021
- Completion date
- Dec 31, 2021
- First posted
- Nov 4, 2020
- Last posted
- Sep 17, 2021
- Enrollment
- 70
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- The Cleveland ClinicLead sponsor
- The Cleveland ClinicReponsible party - principal investigator
- The Cleveland ClinicOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.